江苏普适医药

Jiangsu Pushi Pharmaceutical is a specialty pharmaceutical company headquartered in Taizhou, China, specializing in the development and production of transdermal drug delivery systems (TDDS). The company focuses on high-barrier formulations, particularly patches for central nervous system diseases and chronic pain management. Their product portfolio includes rivastigmine transdermal patches for Alzheimer's disease and lidocaine patches for pain, utilizing proprietary adhesive and drug-in-adhesive technologies. Jiangsu Pushi maintains integrated R&D and GMP manufacturing capabilities to deliver high-quality topical treatments to the global market. The company's platform technology addresses challenges in drug solubility and skin permeability, providing controlled-release solutions that improve patient compliance.